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The cardiovascular systems of animals are affected in different
ways by the three naturally occuring polypeptides angiotensin, oxytocin and
vasopressin. Molecule for molecule angiotensin is the most potent
vasoconstrictor known, and causes a contraction of the vascular smooth
muscle in all the species studied. The vascular actions of oxytocin and
vasopressin are somewhat more variable among different species and in a
given species, it may on occasion produce either a vasoconstiction or a
vasodilatation or be without any apparent effect: That at least part of
this variability in the vascular action of oxytocin and vasopressin is
linked with the circulating levels of ovarian hormones and/or the prevailing
degree of activity in the sympathetic nervous system has been established
over the past decade or so by the work of Pickford and her co-workers. In
the case of angiotensin too there is a great deal of evidence that its
action on smooth muscle is in some way inter-connected with that of the
sympathetic nerve supply to the part. It would be contrary to what one
expects of the economy of biological engineering to find that each of these
three polypeptides initiates a unique and independent chain of events in the
vascular smooth muscle leading to its contraction or relaxation. It is far
more likely that a link in a common chain is affected by each vasoactive
substance. This work was, therefore, an effort to see whether those factors
that had been shown to affect the vascular actions of oxytocin and
vasopressin had any influence on the actions of angiotensin on the
cariovascular system. It is always hoped that this would give a better
understanding of the actions of these polypeptides and some further insight
into the fundamental processes involved in the activation of vascular smooth
muscle.
CHAPTER 1
FACTORS MODIFYING THE ACTIONS OF THE POLYPEPTIDES
VASOPRESSIN
1. Effect of ovarian hormones*
Byrora (1938) showed that a dose of vasopressin which did not have any
effect on immature rats could be made to produce extensive renal infarction
by the prior treatment of such animals with gonadotrophins. Since ovariectomy
protected these animals from the sensitising effect of gonadotrophins and
oestrin administration had a similar sensitising effect he concluded that
oestrogens were responsible for enhancing the response of the vascular
system to vasopressin. Lloyd (1959a) found that rats in oestrus showed a
greater response to vasopressin than dioestrous females. Following
ovariectomy, the dose of vasopressin required to give a constriction of the
vessels of the mesoappendix as observed in a transparent chamber, or the
dose required to give a standard elevation in the blood pressure, increased
after the third post operative day (Lloyd 1959a). However, for some unknown
reason the sensitivity to vasopressin returned to normal on about the seventh
post-operative day. During the period of reduced sensitivity administration
of oestrogen and progesterone to these animals restored the sensitivity to
normal. Honore and Lloyd (l96l) showed that male rats gave a smaller pressor
response than female rats of comparable weight to a given dose of
vasopressin* Following castration male rats were shown to be more sensitive
to the pressor action of vasopressin, the opposite state to that seen in
ovariectoraised females. After the 10th day of pregnancy the pressor response
to vasopressin was again found to be enhanced compared with that of the
dioestrous rat (Lloyd 1959b). An enhancement of the pressor response to
vasopressin in pregnant rats has also been reported by Ostrovsky and Gornall
(1964). In these instances however, either chorionic gonadotrophins or the
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ovariun hormones can be incriminated.
The evidence for a similar sensitising effect of oestrogens in the case
of man are not entirely concordant. Reynolds (1952) found that humans
treated with oestrogens were more sensitive to the pressor action of
posterior pituitary extract. He does not appear to have repeated these
experiments using more purified preparations or synthetic vasopressin.
Browne (1964) showed that pregnancy increases the systolic pressure rise to
an intravenous injection of pituitrin. However he concluded that the
sensitising agent was chorionic gonadotrophins. Un the other hand,
de Vallera and Keller (1938) and Schockaert and Lambillon (1937) find that
pregnant women are less sensitive to vasopressin.
2. Effect of the sympathetic nervous system.
Kepinow (1912) and Niculescu (1914) had reported that pituitrin enhances
the response of blood vessels to adrenaline. Thompson (1938) has confirmed
this both in the intact animal and isolated blood vessels and has found the
enhancement to persist even after constrictor action of vasopressin has
passed off. Melville and Stehle (l93l)» however, failed to confirm these
early findings. Wagner and Braunwald (1956) studied three subjects showing
an autonomic deficiency syndrome and found that they showed a pressor response
to very small doses of vasopressin, whereas, much larger doses were without
effect on normal subjects. This extreme sensitivity to vasopressin cannot be
attributed solely to a lack of sympathetic nervous activity, for these
subjects also showed interference with the parasympathetic system as
indicated by the presence of impotence. These workers also demonstrated
that a similar sensitivity to the action of vasopressin could be induced in
normal subjects by the prior treatment with tetraethyl ammonium chloride
(T.E.A.C.) This fact again though suggestive of participation of the
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sympathetic nervous system in this effect, may be criticised on the grounds
that T.E.A.C. has been shown to have a similar action on several other
vasoconstrictors, suggesting some direct action of this substance on the
vascular smooth muscle in addition to a ganglion blocking action (Lumi&Rash-
leigh 1961} Page and Taylor 1950). In rats, pithing, decerebration, ganglion
block with hexamethonium and tetraethyl ammonium iodide, or peripheral
sympathetic block using reserpine, bretylium, or dihydroergotaraine were all
found to increase the pressor response to vasopressin (Lloyd and Pickford
196l). Atropine however did not affect the response to vasopressin.
Similarly Supek et all (1962) found that in the anaesthetised dog hydergine,
dibenamine and tolasoline increased the pressor response to vasopressin. On
the other hand Youmans and Jtankin (1947) did not find any influence of
dibenamine on the response to vasopressin in the anaesthetised dog: and
Meier, Tripod and Studer (1958) using the perfused hind limb of the rabbit
found that dihydroergotamine and hydergine decreased the response to vaso¬
pressin slightly though llegitine enhanced it. The effect of these drugs is
probably due mostly to the abolition of compensatory reflex mechanisms.
Another possible site for the interaction of vasopressin with the
autonomic nervous system is suggested by the work of McCubbin, Page and
Bumpus (1957) who showed that vasopressin like noradrenaline could diminish
the carotid sinus occlusion reflex when applied locally to the carotid sinus.
Noradrenaline was much more effective at this site than vasopressin and they
probably act by altering the state of contraction, and therefore the resistance
to stretch, of the baroreceptive arterial wall thus modulating the sensitivity
of the receptor to intra-arterial pressure changes. Kezdi (1954) has





1. Effect of ovarian hormones.
The vascular action of oxytocin in the mammal seems to have both
vusoconstrictor and vasodilator components. Thus Gaddum (1928) using the
separated active principle of the posterior pituitary found that the oxytocic
fraction produced a depressor response in cats when the vascular tone was
high after the administration of vasopressin. This effect was not obtained
in all the preparations, while vasopressin always produced a pressor response.
Van Dyke, Adamaons and Engle (1955) showed that in the anaesthetised rat
large doses of oxytocin (300raU) had a blood pressure elevating effect
equivalent to about 4mU of vasopressin while smaller doses caused a fall in
the blood pressure. Using changes in the pulse contOtWto detect
vasodilatation Woodbury at al (1944) found evidence of vasodilatation in
three human subjects which they studied, on the administration of pitocin.
They concluded however that the fall in the blood pressure which they observed
was mainly due to a weakening of the action of the heart. In a latter study
using cats, rabbits and dogs, Woodbury and Abreu (1944) detected a vasodilat¬
ion in the cats and rabbits though not in the normal dogs. Lloyd (1959a)
h
has shown that in male and dioestrus female rats 20 to lOOmU of syndetic
oxytocin produces a vasodilatation of the vessels in the mesoappendix even
though the blood pressure was unaffected. A similar vasodilatation has been
demonstrated in the hind limb of both male and female dogs (Lloyd and Pickford
1962). In man too intravenous injections or intravenous infusions of oxytocin
into males or non pregnant females caused a fall in the blood pressure and a
vasodilatation in the skin and muscle vessels (Mayes and Shearman 1956}
Kitchin, Lloyd and Pickford 1959)* Thus the major action of oxytocin in all
these reports is one of vasodilatation.
6.
Lloyd (1959 a and b) first shoved that unlike dioestrous rats those in
natural oestr^us responded to oxytocin by a rise in blood pressure which
accompanied a constriction of the vessels of the mesentery. Oestrogen
administration to dioestrous or male rats converted their response to
oxytocin from one of vasodilatation to vasoconstriction as observed in the
meseneteric vessels and this was accompanied by a rise in the blood pressure.
In the case of female animals the conversion of the reaction to oxytocin
could be achieved by treatment with either stilboestrol (3»5pg/lOOg body
weight) or progesterone (90}ig/l00g body weight) given 24 hours previously}
while male animals required stilboestrol or stilboestrol and progesterone.
Progesterone alone was inadequate in the case of males. That progesterone is
as effective as oestrogens in the female rat in bringing about the conversion
in vascular response to oxytocin has been confirmed by Fullerton and Morrison
(1965). Ovariectomy lead to a temporary sensitisation to the dilator action
of oxytocin, and the treatment of these animals with stilboestrol and
progesterone in combination restored the oestrous type of constrictor response,
liats from the tenth day of pregnancy to the third day post par turn also
responded by an elevation in the blood pressure. Since this was observed
even when the uterus was excluded from the circulation it was not secondary
to an expulsion of blood from a uterine contraction induced by oxytocin.
Fullerton and Morrison (1965) have observed similar results in pseudopregnant
rats.
In the dog too similar observations have been made (Lloyd and Pickford
1962). Thus intravenous or intra-arterial oxytocin was found to produce a
vasodilatation in the hind limb vessels of both normal male and female dogs;
the blood pressure remained unchanged. Pre-treatment of these animals with
either oestrone or stilboestrol leads to the conversion of this response to
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a constrictor one. This conversion takes place in as short a time as 30 rnins.
after the intravenous administration of an oestrogen. The same phenomenon
has been described in the hand blood flow of man 40 iains. after oestrogen
was injected into a brachial artery (llaigh, Kitchin and Pickford 1963). As
already mentioned, studies on men and non-pregnant women have shown that
oxytocin produces a vasodilatation in them. In contrast however there are
several reports that a proportion of pregnant women respond to oxytocin by
elevation in the blood pressure. This again suggests a basic similarity in
the vascular response to oxytocin in the rat and man.
There are three recent reports however that do not appear to agree with
these findings. Nakano (1964) found that both male and pregnant rats
to
responded^synthetic oxytocin by an elevation in the blood pressure which was
dose dependent in the range of 0.05 to 3«2 units per Kg body wt. In male dogs
that were pretreated wit^diethylstilboestrol (0.25mg/kg for 3 days) as well
as in pregnant dogs Nakano and Fisher (1963) found that oxytocin increased
the flow in the coronary, common carotid, brachial, femoral, & superior
mesenteric arteries when administered in doses ranging from 0.005 to
0.C5u/kg. Katz (1964) has shown that in cats pure synthetic oxytocin in
doses of 1 to 20 units/kg always produced an elevation in the blood pressure.
They attributed the fall in the pressure observed on occasions with the
n
commercial preparation of Sytocinon, to a depressor effect of the
preservative substance in this preparation, viz chlorbutanol. It is
however obvious that all these workers have used very large doses of
oxytocin well outside the doses used by kickford et al, and the results
are therefore not comparable.
2. Effect of the sympathetic nervous system.
Wagner and Brundwald (1956) showed that an infusion of 10 to 20 units
8.
of oxytocin per hour into their subjects suffering from the autonomic
deficiency syndrome produced a brief fall in the pressure followed by a
prolonged rise whereas normal subjects did not show any response to the
same dose. Interference with the autonomic nervous system by pithing,
decerebration, dihydroergotaraine, bretylium,dibenamine, reserpine or
tetraethyl ammonium treatment all caused oxytocin to become pressor
(Lloyd and Pickford 196l). Since in this study other depressor substances
such as isoprenaline or acetylcholine were found not to affect the response
to oxytocin it is certain that the reversal of the action of oxytocin was
not related to a reduction in the vascular tone per se. It is worthy of
note that following reserpine treatment an infusion of noradrenaline failed
to restore the dilator action of oxytocin although the response to tyramine
was increased by this procedure. A similar reversal in the response of the
hind limb vessels of the dog to oxytocin has been observed after acute
sympathectomy or treatment with bretylium, hexaraethonium or dihydroegotamine
(Lloyd and Pickford 19621. In these experiments, the stimulation of the
peripheral end of the cut lumbar sympathetic chain was found to restore the
dilator response to oxytocin (Haigh, Lloyd and Pickford 1964). In dogs with
chronic unilateral lumbar sympathectomy the response of the vessels of the
denervated limb to oxytocin was a vasoconstriction for as long a period as
re-innervation was demonstrably absent (Haigh, Lloyd and Pickford 1965).
Deis, Kitchin and Pickford (1963) have shown that the effect of oxytocin on
the hand blood flow in man can be similarly reversed by blocking the nerveB
to the limb with lignocaine, or by intra-arterial bretylium.
The effect of some of the procedures that reverse the vascular response
to oxytocin on the extracellular cations has also been investigated because
changes in the extracellular concentration of ions are known to influence
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the action of drugs on vascular smooth muscle. No correlation was found
between the cation concentration and the procedures affecting the response
to oxytocin (I'ickford and Lloyd 1966). Induced changes in the extracellular
ion composition as well as drugs that can be expected to modify the ionic
equilibria across the cell membrane were similarly found to be without
effect on the response to oxytocin.
Thus it is clear that the administration of oestrogen and progesterone
or interference with the sympathetic nervous system influences the vascular
actions of vasopressin and oxytocin in the same direction. As pointed out
earlier, exogenous noradrenaline fails to restore the dilator response to
oxytocin following sympathectomy even though stimulation of the peripheral
end of the cut sympathetic chain is effective in this respect. It has been
found, however, that after sympathectomy an infusion of adrenaline can
restore the dilator response to oxytocin. In the situation where oestrogens
have converted the oxytocin response to a constrictor one in the dog, the
intra-arterial infusion of adrenaline alone greatly reduces the constrictor
response to oxytocin; while if atorpine as well as adrenaline is present
the dilator resjjonse to oxytocin is re-established. Similarly in the
presence of atropine sympathetic nerve stimulation is effective in restoring
the dilator response to oxytocin in the oestrogen treated dog or monkey
(llaigh, Lloyd and Pickford 1965). Fullerton and Morrison (1965) have shown
that in the oestrogen treated rat too, stimulation of the central
sympathetica by using eserine (Varagic 1955; Varagic et all 196l) abolished
the vasoconstrictor response to oxytocin. The additional presence of atropine
did not affect the result in any way in this species. It was also found that
eserine failed to influence the response to oxytocin in progesterone treated
rats, and in this respect the effect of oestrogens differed from progesterone
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in this species.
In any of these situations an alpha receptor blocking agent will at
once convert the oxytocin response to one of constriction. Thus adrenaline
infused in the presence of dihydroergotaraine does not restore the dilator
effect of oxytocin (Lloyd and Pickford 1966). This suggests that the beta
receptors are not concerned with these effects, and this is confirmed by the
inability of nethalide to influence either the constrictor or dilator effects
of oxytocin. On the other hand the importance of the alpha receptor is shown
by the fact that an infusion of adrenaline prevents the constrictor response
to oxytocin after hexainethonium.
On the basis of this evidence it has been suggested that the fraction of
adrenaline released by sympathetic nerves is of functional significance, and
is essential in some way for the dilator effect of oxytocin} and that
oestrogens interfere with the manufacture of adrenaline or its release from
the sympathetic nerves. Oestrogens have been shown to increase the acetyl¬
choline content of a variety of organs (Reynolds and Foster 1940} Reynolds
1939)* The necessity for the presence of atropine for the restoration of
vasodilatation after oestrogen conversion in contrast to the sympathectomy
is probably linked in some way with this.
ANGIOTENSIN
1. Effect of the ovarian hormones.
The evidence for an effect of oestrogens on the vascular actions of
angiotensin is of an indirect nature. Harrison,Grollman and Williams (1940)
noticed that in rats with renal hypertension the blood pressure decreased
spontaneously during the last few days of pregnancy and returned to the
previous high level after delivery. They also showed that pregnant rats were
less sensitive to the pressor action of renin. These results were confirmed
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by Page, Fatten & Ogden (l94l) who also found that psexido-pregnancy in the
rat had a similar effect. It is possible to attribute these changes to the
altered hormonal balance of the animal diiring pregnancy, on the other hand
they may be due to some other change brought about by the state of pregnancy.
Further it is by no means established that the pressure elevution in renal
hypertension is due to the excessive endogenous production of angiotensin.
Mackaness and Dodson (1957) found a reduction in the pressor response to
renin in the pregnant rat, but Dodson (1957) vas unable to find any change
in the response to natural angiotensin. Ostrovsky and Gornall (1964) however
using synthetic angiotensin have demonstrated a significant reduction in the
response in the last week of gestation. Mackaness (1959) has shown that
there is a significant reduction in the level of angiotensinogen in the preg¬
nant animal, and attributed the reduced response to renin to this. Page
(1947) on the other hand found that puerperul women needed higher doses of
angiotensin to produce a given elevation in the blood pressure when compared
with non-pregnant women, and concluded that this was due to an increase in
the level of angiotensinase. Chesley (196?) too has found that pregnant
women are less responsive to angiotensin. Abdul-Karim and Assali (l96l)
showed that both the height and the duration of the pressor response to
angiotensin was reduced during pregnancy and that the smallest responses were
observed in women near term. The latter finding suggests that the change in
the response to angiotensin vas not directly related to the increase in the
blood volume as this usually reaches a maximum in the seventh and eighth
month of gestation and decreases towards terra.
The only study of a direct action of oestrogens on the response to
angiotensin appears to be that of Page and Helracr (1940) who found no change
in the pressor effect following stilboestrol administration.
2. Effect of the sympathetic nervous system.
There is evidence that angiotensin may interact with the autonomic
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nervous system et more than one point.
II
Von Euler and Sjostrund (l94l) showed that in cats and rabbits
decerebration at a level below the posterior corpora quadrigemina reduced
the pressor response to natural angiotensin, while transection above the
superior corpora leaves the action of angiotensin unaltered or even enhanced.
That these effects were not secondary to changes in general vascular tone
were shown in experiments where parallel reductions in the blood pressure
were produced by haemorrhage or manipulation of the viscera. Bickerton
and Buckley (1961) cross circulated a dog's head with blood from a donor
animal and shoved that the injection of 0.2 to 0.4jig of angiotensin into
the head circulation of the recipient caused a pressor effect in its
general circulation which was abolished by pre-treatment with piperoxan or
besodioxan. The pressor effect of an intravenous injection of angiotensin
into the recipient animal was unaffected by these two drugs. Denervation of
the carotid sinus left the effect of angiotensin in the head circulation
unaltered. A brief occlusion of the circulation to the head to mimic a period
of anoxia, as may be caused by a cerebreal vasoconstrictor action of
angiotensin, also failed to produce a response in the recipient animal.
Any possible leak between the head circuit and the recipients general
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circulation was excluded by injection of I into one circuit and
analysing blood from the other. This then is strong evidence for a central
action of angiotensin. More recently Buckley (1965) has shown that urinary
adrenalins but not nor-adrenalirie excretion is increased in the recipient
during the introduction of angiotensin into the head circuit. Benetato et
al (1963) have confirmed these findings and also made the interesting observ¬
ation that atropine or reserpine treatment (given 12 hours before) abolished
these central actions of angiotensin, and that in reserpine treated animals
the central effect can be restored by an infusion of noradrenaline into the
cerebral circulation. This suggests the presence of a cholinergic as well
as a adrenergic link in the central mechanism activated by angiotensin.
Similarly in cross circulation experiments Laverty (1963) has found that
angiotensin intravenously, in large doses, caused a vasoconstriction in the
vascularly isolated but inervated hind limb of the rat. Smaller doses of
angiotensin I.V. produced a vasodilatation in this preparation as did
noradrenaline. That these were nervously mediated changes was confirmed by
the fact that they were abolished by section of the nerves. Dickinson and
Lawrence (1963) have shown that an infusion of small quantities of
angiotensin, insufficient to produce a direct pressor action
(0.005 to 0.0075 pg/kg/Min.,) into conscious rabbits over a period of days,
leads to a gradual elevation of their blood pressure. Since this elevation
in the blood pressure can be restored to the pre-infusion basal level by the
administration of the short-acting ganglion blocking drug trimetaphan
(Arfornad) it is likely to be due to an increase in the activity of the
sympathetic nerves (Yu and Dickinson 1905). On the grounds that such an
infusion of angiotensin when made into a vertebral artery was more effective
than an intravenous one, these workers suggest that the increased sympathetic
nerve activity is secondary to a vasoconstriction produced in the region of
the medullary vasomotor centre. These findings can however be equally inter¬
preted as being due to a direct action of angiotensin on the nerve centres,
specially as Mandel and Sapiratein (1962) have shown that sub-pressor doses
of angiotensin increase rather than decrease the cerebral blood flow. The
infusion of sub-pressor quantities of angiotensin over long periods have been
shown to produce similar elevations of the blood pressure in the dog
(McCubbin et al 1965) rat (Koletsky, Rivera-Velez and Pritchard 1965)
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and man (Laragh, Cannon and Ames 1964).
Using an ingenious technique Berry, Austen and Clark (1964) divided the
circulation of anaesthetised dogs into a cardiopulmonary circuit and a systemic
circuit. The only possible connection between the two circuits was through
any collaterals of the bronchial circulation. In this preparation when
angiotensin was injected into the systemic circuit it produced a positive
inotropic and chronotropic effect while when it was injected into the
cardiopulmonary circuit so that it could reach the heart directly it had the
opposite effect. The positive inotropic and chronotropic effects were abolished
by the beta receptor blocking drug nethalide. The positive inotropic and
chronotropic effects when angiotensin is introduced into the systemic circuit
is therefore probably a central action of angiotensin.
Gregory, Levine and Lindley (1944) however found that angiotensin
caused equal rises in pressure before and after spinal anaesthesia in both
hypertensive and normotensive human subjects. In dogs too they found that
vagotomy and low section of the spinal cord did not affect the response to
angiotensin. Against this negative finding in man is the report of Scroop
and Whelan (1966) that an intravenous infusion of angiotensin produced a
vasoconstriction in the hand and that this was greatly reduced by the prior
administration of phenoxybenzamine or bretylium. This response was found to
be absent in surgically sympathectoraised or nerve blocked hands. This clearly
points to a central action in man as well but whether this action is on the
vasomotor centre or some other site has not been established.
Another possible site at which angiotensin and the autonomic nervous
system may interact is at the ganglion, or at its equivalent the adrenal
medullary cell.
Braun Menendez et al (1940) observed that the injection of angiotensin
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caused the discharge of adrenaline from the denervated adrenals, ilenson,
Barac and Bacq (1959) noticed that after treatment with cocaine,angiotensin
caused a contraction of the nictitating membrane in the cat and that this
effect was blocked by phenoxybenzamine. Feldberg and Lewis (19&4) demonstrated
that in the eviscerated eat the injection of angiotensin into the coeliac
artery so that it reached the adrenals produced a release of catecholamines
as shown by the contraction of the denervated nictitating membrane of the
animal. In a sensitive preparation as little as lng intra-arterially could
be shown to cause the release of catecholamines. 0.1 to 0.2 jig of
angiotensin intravenously had a similar effect, and adrenalectomy abolished
these effects. The simultaneous changes in the blftod pressure suggested
that the main catecholamines released in this way was adrenaline. Other
vasoconstrictors were ineffective in this respect while the vasodilator
bradykinin could also liberate catecholamines from the adrenals. This
latter finding is against the suggestion made by ^aneko et al (l96l) that
the release of adrenaline which they had observed earlier with the intra¬
arterial injection of a number of vasoconstrictors including angiotensin,
after a sensitising dose of 33MPP is due to the local tissue hypoxia from
local vasoconstriction. Vogt (1965) has confirmed Feldberg and Lewis'
findings using isolated perfused adrenals and estimation of the released
catecholamines by chemical means. Feldberg and Lewis (1965) have
subsequently shown that chronic bilateral splanchnic nerve section or the
administration of hexametonium which reduces the sensitivity of the medulla
to acetylcholine, were both without effect on the sensitivity of the adrenal
medulla to angiotensin. There would therefore appear to be different receptors
on the medullary cells for acetylcholine and angiotensin.
Lewis and Iteit (1965) demonstrated that the close intra-arterial
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injection of angiotensin into the superior cervical ganglion of the cat
caused a contraction of the nictitating membrane. The smallest effective
dose of angiotensin in this respect was O.ljig which is comparable to the
dose of other naturally occuring substances required to excite the ganglion.
Hexamethonium was without any influence on this action but removal of the
ganglion or sectioning of the post-ganglionic nerves abolished the response.
Tachyphylaxis developed to the action of angiotensin but when this had
occured acetylcholine was still effective in exciting the ganglion. Chronic
decentralisation of the ganglion lead to sensitisation to the stimulating
action of angiotensin. These workers therefore came to the conclusion
that angiotensin exerts a ganglion stimulating action by combining with
receptors different from those concerned with acetylcholine induced
stimulation. These results have been confirmed by PanissetjBiron and
Beaulnes (1966) who found in addition that the stimulating effect of
smaller doses of angiotensin on the ganglion could be blocked by atropine
and hexamethonium though larger doses were not influenced by these drugs.
Like Lewis and Heit they found that when the preganglionic nerve was
stimulated submaximally retrograde injection of angiotensin towards the
ganglion in a dose of 0.01 to O.lng resulted in an enhancement in the
response to subsequent stimulation. In smaller doses however (0.001-0.Olng)
angiotensin had a inhibitory effect on preganglionic nerve stimulation.
It is interesting that this inhibitory action of angiotensin was prevented
by dihydroergotamine — a finding that could implicate noradrenaline in the
synaptic effect of angiotensin. That noradrenaline can have an inhibitory
action at the synapse was shown by Marrazzi (1939). Such a dual action of
angiotensin at the ganglion is in agreement with the observation of Haefely,
Hurlimann and Thoenen (1965).
Further evidence for an effect of angiotensin on ganglia comes from
observations of its action on the gut. ilobertson and iiubin (1962) demonstrated
that in the rabbit and guinea-pig ileum, angiotensin induced contractions as
well as contractions due to acetylcholine and nicotine, could be potentiated
reversibly by the anti-cholinesterase drug BW284C51. Atropine at doses that
reduced the response to nicotine also reduced the response to angiotensin.
Botulinum toxin was found to abolish the response to nicotine and angiotensin
while being without effect on the response of this preparation to acetylcholine.
The conclusion that in this preparation too, a large part of the stimulating
action of angiotensin is due to an action on the ganglia in the wall of the
gut is therefore inescapable. Since in this preparation hexamethonium was
without effect on the angiotensin response but abolished the response due
to nicotine it suggests that in this tissue as well, angiotensin is acting on
non-acetylcholine receptors on the ganglion cell.
In the isolated guinea-pig vas deferens angiotensin strongly potentiates
the response to electrical stimulation of the hypogastric nerve, although
angiotensin has no direct effect on the vas (Benelli, Bella Bella and Gandini
1964). Noradrenaline and acetylcholine, both of which contract the vas, were
not similarly affected by angiotensin. Although the hypogastric nerve was
originally described as a postganglionic sympathetic fibre, it is now certain
that ganglionic cells are interposed (Sejostrand 1962; Merrillees, Burnstock
and Holman 1963). It is therefore likely that in this situation too
angiotensin is acting at a ganglionic site, probably playing a permissive
role in the transmission through the ganglion. However, the pharmacology of
the vas deferens - hypogastric nerve preparation must still be regarded as
problematical firstly since some reports suggest that the nerve is a mixed
one (Delia Bella, Gandini and Preti 1964) with both sympathetic and
parasympathetic efferent pathways, secondly since treatment with anti-nerve
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growth factor leaves the hypogastric nerve ganglia unaffected, and thirdly
since it has been shown that adrenegic blocking agents modify only slightly
the effect of electrical stimulation while abolishing the response to
exogenous noradrenaline (Delia Bella, Gandinimand Preti 1964; Boyd, Chang
and Rand i960).
Benelli, Delia Bella and Gandini (1964) have also shown that in
anaesthetised or spinal cats a depolarising ganglion block with nicotine or
tetraethyl ammonium diminished the pressor response to intravenous
angiotensin; but if the dose of nicotine is increased so that the block
becomes of the competitive type the pressor response to intravenous
angiotensin is greatly enhanced. This enhancement was abolished by treatment
with hexamethonium. Trendelenberg (1961) has shown that when histamine and
pilocarpine were acting as ganglion stimulating drugs, competitive ganglion
block with nicotine produced an enhancement of the response to these drugs
and that hexamethonium prevented this enhancement. By analogy with these
two drugs therefore, angiotensin would appear to be acting as a ganglion
stimulator in this instance too.
McGiff and Itskovitz (1964) has demonstrated, that in the dog,
vasoconstriction in the renal vascular bed on intravenous injection of
angiotensin into the animal could be abolished by renal denervation while
direct injection into the renal artery was still effective in producing a
vasoconstriction. McGiff and Fasy (1965) subsequently showed that bretylium,
guanethadine or reserpine treatment was also effective in abolishing the renal
vasoconstriction due to intravenous angiotensin, while pentolinium and
hexamethonium were ineffective. They further observed that a parallelism
existed between the action of nicotine and angiotensin on the renal vasculature.
Thus when nicotine had lost its vasoconstrictor effect after repeated injection,
Jty.
angiotensin too was found to have lost its effect? and injection of
nicotine reduced the response to an intravenous injection of angiotensin
given subsequently. These results again appear to point to a ganglionic
site of action of angiotensin.
A mode of action at the ganglion completely different from that
described so far has very recently been suggested by Panisset (1967). lie
has shown that angiotensin in a dose of 0.1 to lOOng increased the
acetylcholine output from the perfused superior cervical ganglion. In larger
doses however the acetylcholine output was inhibited. Angiotensin was
similarly found to increase the output of acetylcholine from electrically
stimulated guinea-pig ileum. This would suggest that angiotensin is acting
at the pre-synaptic membrane, or as an anticholinesterase.
Perhaps the first to show that angiotensin may interact with the
sympathetic nervous system at a peripheral site as well was Mylon and Heller
(1948). They showed that in the isolated rabbit ear perfused with
physiological saline natural angiotensin alone was not a constrictor, but
when combined with traces of adrenaline, which by itself were not pressor,
produced a strong vasoconstriction. They came to the conclusion that the
tyrosine contained in the molecule of angiotensin was of importance for this
action since the amino-acid tyrosine in combination with adrenaline gave a
powerful constriction. It is evident however that their preparation of
angiotensin was not pure as it produced a vasolilatation when given by
itself. Using the same preparation Sakurai and Hashimoto (1965) have shown
that synthetic angiotensin greatly potentiated the response to noradrenaline
and tyramine.
McCubbin and Page (19&3) demonstrated that the infusion of angiotensin
into anaesthetised dogs increased the vascular responses to tyramine
20.
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ephidrine, and DMPP. Since there is evidence to show that tyramine and
ephidrine release catecholamines stores and DMPP can be expected to do the
same through its ganglion stimulating action they suggested that angiotensin
either sensitises the release of noradrenaline or sensitises the vascular
receptor to nor-adrenaline. The latter possibility is rendered unlikely as
they could find no change in the pressor action to injected noradrenaline.
It is worth noting that this sensitising action of angiotensin persisted
even after tachyphylaxis to its pressor action had been induced. Interference
with the sympathetics by ganglion block, spinal cord section or bretylium
treatment immediately abolished the sensitising effect of angiotensin on the
response to tyromine or ephidrine. Using a constant flow perfusion technique
they also showed a similar sensitising action of angiotensin on the responses
of the vascular bed supplied by the superior mesenteric artery of the dog to
intra-arterial tyramine. On the other hand they failed to demonstrate a
similar effect in the hind limb circulation. On the basis of these findings
McCuhbin and Page postulate that angiotensin increases the amount of
endogenous noradrenaline released in response to a given stimulus. However
O
Buckley (19&5) has failed to find any effect of angitensin on the response
of the isolated perfused rabbit kidney to tyramine.
Zimmermanfiatudied the effects of angiotensin on the hind limb vessels
of the dog by introducing a constant flow pump between the cut ends of the
aorta so that changes in the vascular resistance induced by drugs introduced
intra-arterially gave rise to proportionate changes in the perfusion pressure.
He found that ganglion block using hexamethonium or surgical sympathectomy
at the level of lumbar f> reduced the responses to angiotensin while leaving
the responses to noradrenaline and tyramine unaffected. Stimulation of the
peripheral end of the cut sympathetic trunk partially restored the response
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to angiotensin, but an infusion of nor-adrenaline was ineffective in this
respect. Cervical spinal cord section was found to have an effect similar
to lumbar sympathectomy. lie therefore concluded that the normally functioning
sympathetic nerves were capable of facilitating the response to angiotensin
although a more precise mechanism for this effect was not apparent from his
experiments. Baum's (1963) results, using the same experimental arrangement
confirm that acute sympathectomy reduced the response of the hind limb vessels
of the dog to angiotensin, and have shown in addition that reserpine pre-
treatment (0.2 mg/kg i.m. 48 hrs. before) can produce a similar result.
Several reports also suggest that the effects of angiotensin on the
peripheral sympathetica may be to cause a release of noradrenaline from the
nerve terminals. Krasney et al (1965) using anaesthetised dogs with
denervated baroreceptors found that angiotensin had a positive inotropic and
chronotropic effect which could not be abolished by spinal cord section
at cervical six, bilateral removal of the sympathetic chain or ganglion
block. Bretylium, however, abolished and beta receptor blocking drugs
greatly reduced this effect of angiotensin on the heart thus suggesting an
influence on adrenergic nerve endings. Beaulnes (1963) found that the
development of tachyphylaxis to the inotropic and chronotropic action of
angiotensin on isolated atria can be prevented by noradrenaline and that
diehlorisoproterenol partially blocks the action of angiotensin on this
preparation, suggesting again a peripheral site of action of angiotensin on
the cardiac sympathetica. Downing and Sonnenblick (1963) observed a
persistent depression of the ventricular function curve of dogs' hearts
after an infusion of angiotensin and this could not he attributed to a
spontaneous deterioration of the preparation. They therefore suggested the
possibility that it was due to a chatecholamine depletion which had occured
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during the angiotensin infusion. Distler, Liebau and Wolff (19&5) have shown
mo<Ts
that mammalian arterial strips lose 40-60$^of their noradrenaline content when
washed with Tyrode containing angiotensin as compared with strips washed in
plain Tyrories solution. When rat aortic strips were made to contract by
repeated applications of angiotensin the contractions grew weaker in an
exponential manner} rinsing the preparation in noradrenaline solution
(lO~^g/inl) for 10 mins. restored the response to angiotensin, and cocaine
was found to prevent this restoration by noradrenaline. Feldberg and Lewis
(1965) demonstrated that large intravenous doses of angiotensin produce a
delayed contraction of the nietatating membrane in adrenalectomised cats.
They concluded that this must be due to the release of catecholamines from
the adrenegic nerves or extra-medullary chromaffin tissue. However, Muscholl
and Vogt (1964) could not demonstrate that angiotensin released catecholamines
from extra-medullary chromaffin tissue in the dog though nicotine was quite
effective in this respect.
Earlier Benelli, Delia Bella and Gandini (1964) had found that in the
isolated perfused cat spleen preparation, angiotensin in doses too small to
cause a direct contraction, greatly potentiated the splenic contraction induced
by nerve stimulation. Two recent attempts have been made to elucidate the
mechanism of this potentiation. Hertting and Suko (1966) using a constant
pressure perfusion technique confirmed that angiotensin potentiated the
response of the spleen to nerve stimulation. They were however unable to
find any definite difference in the total catecholamine output during periods
of nerve stimulation in the presence of absence of angiotensin. On the other
hand a vasoconstriction produced by vasopressin or stopping the perfusion
prior to nerve stimulation produced a potentiation of the splenic volume
change in the same way as did angiotensin. They concluded therefore that
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angiotensin acted by producing a vasoconstriction in the spleen thereby
increasing locally the concentration of the noradrenaline liberated from
the nerve terminals. They also showed that after chronic denervation or
reserpine treatment,when the noradrenaline content of the spleen was less
than 0.02pg/gm and tyramine was rendered inactive, angiotensin still produced
a contraction of the spleen as well as a vasoconstriction. Since, however,
they used a constant pressure prefusion technique which allowed changes in
the rate of flow of the perfusate to occur, and since the size of the spleen
as well as the amount of noradrenaline leaving the spleen can be affected by
this in a complicated way, the interpretation of their results are not
entirely certain. Thoenen, Ilurlimann and Haefely (1965) using the more
acceptable constant flow perfusion technique have again confirmed that
angiotensin potentiates both the increase in the vascular resistance and
the change in splenic volume produced by nerve stimulation. The change in
the vascular resistance was potentiated more (70$) than the splenic contraction
(20-30$). The noradrenaline output was however not measurably altered by
the presence of angiotensin. Nor could angiotensin be shown to influence
the uptake of noradrenaline infused into the spleen. These workers there¬
fore came to the conclusion that the site of the enhancing action of angiotensin
lies at the level of the smooth muscle cell. Against the failure to show
an interference of the re-uptake of noradrenaline in these two studies is
the recent report of i'alaic and Khairallah (1967). They have shown that at
an angiotensin concentration of 20pg/ral in the incubating medium
noradrenaline uptake is inhibited in spleen and brain slices to the extent
of 50$, while in rat aortae a 30$ decrease in uptake was observed. These
workers state that the high concentration of angiotensin in the medium was
rendered necessary because of the powerful angiotensin destroying properties
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of the tissues.
Against a catecholamine releasing role for angiotensin are the findings
of Buckley (1965) who could detect no change in the catecholamine content in
rabbit kidneys which were perfused with angiotensin for one hour. Similarly
hearts and kidneys of rats receiving l.Ojig/kg/rain. of angiotensin intra¬
venously for one hour failed to show a change in their catecholamine contents.
However in such an experiment the catecholamine releasing effect of
angiotensin on the adrenal medulla would have to be taken into account.
More direct evidence for an effect of angiotensin on the catecholamine
content of nerve terminals conies from the electron microscopic studies of
panagiotis and Hungerford (1966). They have shown that the subcutaneous
administration of 6ug of angiotensin per day for 12 days into rats can sig¬
nificantly increase the number of granulated vesicles in the nerve terminals
of the pineal glands. The pineal gland is known to be richly supplied with




DEFINITION OF THE AREA REQUIRING INQUIRY
It is clear from the preceeding survey of the literature that oestrogen
and progesterone exert a marked effect on the action of the two polypeptides
oxytocin and vasopressin. In the case of angiotensin pregnancy has been
shown to have some influence on its vascular action. Whether this can be
attributed to an effect of the ovarian hormones does not appear to have been
definitely looked into and this suggested itself as the initial line of
experimentation. In view of the known effects of the ovarian hormones on
water and electrolyte metabolism it was felt that an inquiry had also to
be made into any effects of changes in the electrolyte composition of the
extracellular fluid on the action of the polypeptide hormones.
The evidence from the use of blocking drugs as well as acute and
chronic sympathectomy have shown that the withdrawal of sympathetic
influences has a similar action to the presence of the ovarian hormones on
the vascular effects of oxytocin and vasopressin. In the case of angiotensin
sympathectomy has been shown to decrease the vasoconstrictor action in the
hind limb of the dog and a great deal of work on different species indicate
that it may interact with the sympathetic nervous system at a central,
ganglionic and peripheral site. Yet the effect of blocking drugs on the
vasoconstrictor action of angiotensin does not appear to show a consistent
pattern (Nickerson, Bullock and Nomaguchi 1948} Supek et al 1962; Prado
and Carlini 1959} Bianchi et al 1960} Yonkman, Jeremias and Btilwell
1943} Braun-Henendez and Fasiolo 1940}). Part of these differences are
no doubt due to differences in the experimental set up and the species of
animal used. It was therefore decided to determine the effect of blocking
drugs on the pressor response to angiotensin in the rat and dog, the two
species used chiefly in this study and in the earlier work with oxytocin
and vasopressin.
A peripheral interaction between angiotensin and the sympathetica have
been shown by others. It appeared necessary to attempt to ascertain the
exact site of this interaction. An isolated artery preparation was used
with this end in view.
For convenience of presentation the results are divided into three
sections, those obtained using rats, those obtained using dogs and those





Albino rata of approximately 200g body weight were used throughout to
obviate the necessity for estimating comparable doses of drugs in different
animals. Pentobarbitone 5mg/l00g body weight was used as the anaesthetic
in all animals. To avoid any obstruction to respiration the trachea was
cannulated. A Condon mercury manometer writing on a smoked paper was used to
register the blood pressure from a polyethylene cannula inserted into a
common carotid artery. This cannula contained a small quantity of heparin
solution to prevent clotting. A fine polyethylene cannula was also inserted
into a femoral vein for the administration of drugs. Drugs were dissolved
in isotonic saline so that the required dose was contained in 0.05 ml. This
was then immediately washed in with 0.05 ml. of saline the dead space of
the venous cannula being of the order of 0.02 ml. The angiotensin used was
the synthetic valine 5 angiotensinamide (Ciba). When experiments involved
the infusion of substances both femoral veins were cannulated and the infusions
were made via one of the veins using a Palmer continuous infusion pump while
the other vein was used for the administration of angiotensin. In experiments
involving the collection of blood for electrolyte analysis, the animal was bled
from an arterial cannula. Pseudopregnancy was induced by placing a
vasectomised male in the cage with the females. The stage of the reproductive
cycle and the onset of pseudopregnancy were ascertained by examining vaginal
smears.
RESULTS AND DISCUSSION
1. Effect of ovarian hormones on the response to angiotensin.
The maximum elevations in the blood pressure produced by three different
doses of angiotensin (2,4 and 8 nanograms), administered in random order, to
female animals in different phases of the oestrus cycle, male, pseudo-
pregnant and pregnant animals were measured. Preparations which did not
give steady baseline blood pressures, making measurement of changes difficult,
were discarded. This difficulty was encountered particularly in male animals*
In the doses used there was no evidence of tachyphylaxis and the response
in a given animal was reproducible. At least 5 mins. were allowed after the
blood pressure returned to the basal value before administering another dose
of angiotensin. The pressor response to a given dose did not appear to be
related to the level of the basal blood pressure. An analysis of variance at
each dose level showed that the mean responses of female animals in oestrus,
dioestrus and pro-oestrus as well as of male animals did not differ
significantly (i>0.05){ although oestrous animals gave higher responses at
all dose levels. The results of these groups were therefore pooled and used
for comparison with other groups. The significance of difference was tested
by an analysis of variance. The results are summerised in table 1 and figure 2.
Significantly lower responses than normal were observed in pregnant as
well as pseudopregnant animals, particularly at the higher dose levels.
(P values in table). Since a feature coimnon to both pregnancy and pseudo-
pregnancy is the presence of a functional corpus luteum, the possibility that
the observed difference in the responsiveness was due to the presence of
progesterone was considered next. Female rats were given progesterone in
Arachis oil as a single subcutaneous injection in three different doses and
tested with angiotensin 24 hours later. 0.2 and 0.6 mg. of progesterone
produced a reduction in the response to angiotensin but this reduction
reached significance only at the lower dose. The addition of sodium oestradiol
sulphate at two different doses did not produce any further change. This
suggested that progesterone may he the basis for the reduced responses to
angiotensin in pregnancy and pseudopregnancy. The possible mechanism of
action of progesterone must be considered next*
Pregnancy is known to produce an increase in the extra-uterine weight
(Newton 1935), and the humoral basis for this has been shown to be the
secretion of progesterone (l)ewar 1957a, Newton 1935? Hervey and Hervey 196?)•
This gain in weight is due to retention of water as well as an increase in
the protein and fat content of the body. (Brooksby and Newton 1938; Dewar
1953? Pewar 1964; Hervey and Hervey 1967), and amounts to about 20$ of the
initial body weight. Hervey and Hervey (196?) have established that in
their rats treated with progesterone the proportion of the increase in
the weight attributable to water was 51$ in one group and 61$ in another.
However, of this, only 22$ in one instance and 28$ in the other was retained
without protein and ash, on the basis of the usual ratio of protein to water
in the lean tissues. It is therefore only this amount of water that is
likely to have been added to the extracellular fluid. This \«mld lead one
to expect an increase of approximately 5$ in the blood volume. Bond (1948)
has shown that after 21 days of gestation the blood volume of rats increased
by 6.6$. Similar considerations apply in the case of pseudopregnancy
(Dewar 1957b). Both the increase in the blood volume and the increase in
the weight of the animal could have played a part in reducing the response
to angiotensin since these animals received the same dose as the controls
which were some 15 to 20g. lighter. It has however been noticed that the
weight of the animal can vary between 150 to 300g. without any noticeable
change in the response to a given dose of angiotensin. Further the mean
reduction in the pressor response (42.8$ for pregnant and 30.4$ for
pseudopregnant) is much greater than the changes in the blood volume that
can be expected. The observed differences are therefore unlikely to have
arisen from this cause.
ilervey and Hervey (1967) have shown that the rate of increase in the
weight as well as the total weight increase produced in rats by progesterone
treatment is linearly related to the logarithm of the dose of progesterone
for doses ranging from 0.2 to lOmg./day. If therefore the reduction in the
responsiveness to angiotensin in the progesterone treated animals is also to
be accounted for by a retention of water and the resultant increase in the
blood volume, the higher doses of progesterone would be expected to produce
a greater effect. This, however is not the case as the largest effect is
seen at the intermediate dose of 0.2mg. Further, since these doses of pro¬
gesterone were given only once and the animal tested 24 hours latter
significant amounts of water are unlikely to have been retained. The doses
of progesterone used are within the physiological range. Mayer (1963) and
Miayake (1962) have found that 1 to lGmg./day of exogenous progesterone
is required to secure implantation and continuance of pregnancy in rats
that are ovariectomised soon after mating} 5mg/day of progesterone were
required to reproduce a physiological situation similar to pregnancy in
Hervey and Hervey'a study, and at this dose level the plasma progesterone
was about 0.06 to 0.12 pg/ml (Bullock and Cook 1967)*
Another possibility is that progesterone in some way interferes with
sympathetic transmission. In view of the numerous reports showing that
in the absence of sympathetic nervous activity the response to angiotensin
is reduced, this mechanism can explain the observed results. That
progesterone may act in this way has been suggested by the similarity in the
effect of sympathectony and progesterone rich states on the responses to
oxytocin (Pullerton and Morrison 1965). There is also some evidence for
an action of progesterone at the hypothalamic level (iiarraclough ly02j
Szentagothai et all 1962 Lloyd 1963) though not on the sympathetic outflow
as such.
Kaplan and Silah (1964) and Gross Brunner and Ziegler (1965) have
marshalled evidence to show that the sensitivity of the rat as well as other
species to the vasoconstrictor effect of angiotensin varies inversely with
the level of endogenous angiotensin and renin in the plasma. That
progesterone might activate the renin angiotensin system is shown by the
following considerations. Although some observations show that progesterone
has a weak salt and water retaining action (Thorn and Engel 1938| Thorn
Nelson and Thorn 1938? Gaunt, Nelson and Loomis 1938| Gaunt and Hays
1938), Landau and Lugibihl (1958) have shown that progesterone can act as
an aldosterone antagonist at the renal tubular level thus giving rise to
sodium depletion. Sodium depletion has been shown to be one of the factors
quite consistently associated with an increased plasma renin level suggesting
its increased secretion (Brown et all 19*6). Direct evidence for an elevation
of renin in pregnancy has been found by Fasciolo et all (1964) and Brown et
all (1963), while Pickens et all (1965) have shown renin substrate level is
also elevated in pregnancy. Laidlaw, Ruse and Gornall (1962) gave progesterone
to six nonpregnant subjects and found that it produced increased urinary
excretion of aldosterone in all of them and increased aldosterone secretion
in two subjects in whom this was measured. Since the renin angiotensin
system has been established as a stimulator of aldosterone secretion in man,
it is reasonable to assume that renin secretion was also elevated in these
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subjects. Similar results have been reported by Watanabe et al (1965).
Winer (1965) reported that the daily administration of progesterone to dogs
lead to a doubling of the plasma renin levels within four days.
The exact manner in which an increase in the endogenous renin production
brings about a reduction in the sensitivity to exogenous angiotensin is not
clear and several possibilities present themselves. Bock and Gross (1961) have
demonstrated that cross tachyphylaxis occurs between renin and angiotensin
when these substances are injected into an animal and this may account for
the phenomenon under discussion. The effect of aldosterone, which may be
produced by the increased levels of endogenous renin and angiotensin, on
the vascular responsiveness to exogenous angiotensin is controversial. Katz
et al (1963) have shown that in the rabbit and rat aldosterone administration
markedly decreases the response to angiotensin. Ostrovsky and Gornall(l964)
have reported a reduction in the duration of the pressor response rather
than a reduction in the peak response after prolonged aldosterone treatment.
On the other hand Kaplan and Silah (1963) have reported increased responsiveness
to Angiotensin in primary hyperaldosteronism and McCaa et al(l967) have also
reported an increased responsiveness in aldosterone treated dogs. Although
the role of angiotensin in the secretion of aldosterone is well established
in the case of the dog, there is some doubt whether it plays a similar
role in other species, particularly the rat. Indirect data suggest 6P
aldosterone stimulating action in the rat too but experiments designed
to establish this have not succeeded (Cade and Perenich 1964; Marieb
and Patrick 1965; Eilcrs and Peterson 1964). Therefore the vascular
effect of a secondary elevation of aldosterone may not be relevant to the
present discussion as these experiments were done on rats. The most likely
explanation seems to be that the increase in the renin levels and the reduction
in the responsiveness to angiotensin are effects arising from some other
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conaiion cause such as the reduction in the extracellular sodium. The experiments
described under section 3 below were made in an effort to explore this aspect.
It may therefore be concluded that oestrogens do not influence the
responsiveness to angiotensin while progesterone affects the vascular respon¬
siveness to angiotensin in a direction opposite to that of vasopressin and
oxytocin.
2. The effect of drugs blocking the action of the autonomic nervous system.
The mean maximum response to a dose of angiotensin was determined
before and after the administration of the drug bo that each animal acted
as its own control except in the case of reserpine. The significance of the
differences in the means was assessed by the 't* test. In the case of
reserpine which was administered for two days V0.5mg/day), the mean responses
were compared with those of the normal animals by analysis of variance.
Dihydroorgotamine (D.H.ii.) and reserpine produced a lowering of the basal
blood pressure while eserine produced a temporary elevation. The reserpine
treated animals required only about 2/3 the usual dose of pentobarbitone.
The responses were significantly different only in the roserpine treated
groups (see table for 1' Values). That this was not simply the result of a
lower basal blood pressure was shown by the observation that reduction in the
pressure caused by D.K.E., isoprenaline infusion or pithing did not have a
similar effect. Because of the large number of possible sites of action of
reserpine the interpretation of these results is hazardous. (Jne possibility
that must be considered is that in reserpine treated animals the cardio¬
vascular buffer reflexes may be in abeyance so that greater pressor responses
can occur. However if this were the case an effect in the same direction
should occur in the case of D.H.E. and hexamethonium. To get more information
on this effect of reserpine a pharmacological approach was made by studying
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the effect of a variety of other drugs having related effects. The number
of animals in these groups were too small for statistical treatment of the
results which are summarised separately in table 3« bike reserpine,
desmethy1imipramine, guanethadine, bretylium and amphetamine all increased
the response to angiotensin, while phenoxybenzaraine did not show any great
effect. Except for phenoxybenzamine all these drugs also produce an
increased response to injected noradrenaline, desmethylimipramine,
amphetamine bretylium and guanethadine probably by interfering with the
re-uptake of noradrenaline into the nerve terminals (Axelrod, Whitby and
Hertting 1961} Dengler, Spiegel and Titus 1961} Titus and Spiegel 1962;)
and reserpine by a different mechanism (Trendelenburg 1963)*
Phenoxybenzamine has also been shown to interfere with the nerve membrane
uptake of noradrenaline, but at the same time blocks the alpha receptor
site so that the effect is not manifested as an increased sensitivity to
injected noradrenaline. These findings are therefore consistent with the
suggestion that at least part of the pressor action of angiotensin is due to
a liberation of noradrenaline from a peripheral site. However, once again
because of the multiple sites of action of these drugs interpretation is
difficult. An attempt was made to define the effects of these drugs on
the isolated hind limb vessels of the rat perfused with the rats own blood,
but it had to be abandoned due to difficulties in getting steady basal
perfusion pressures and consistent responses to angiotensin. Following
reserpine treatment the time course of development of increased pressor
sensitivity to angiotensin was followed in a aeries of animals. The
earliest development of an increased sensitivity was observed about 12 hours
after treatment and the effect was nearly complete 24 hours after treatment.
Adrenalectomy did not influence the effect of reserpine.
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In the effect following the administration of drugs blocking the
sympathetic nervous system, therefore, angiotensin shows some similarity
to vasopressin and oxytocin by producing enhanced pressor responses} but
the mechanism underlying this increase in response is probably different in
the case of angiotensin.
3. The effect of changes in extracellular ions.
The effect of acute changes in the sodium, potassium and calcium
concentration in the extracellular fluid was studied. After preparation
of the animal 0.5ml. of blood was collected by bleeding slowly via the
arterial cannula which was then connected to the mercury manometer for
recording the blood pressure. Several responses to 4nanograras of
angiotensin were recorded and then cither 2M disodium hydrogen sulphate
solution (pH 7.4) or potassium chloride (40mg/ral) or calcium gluconate
(l0>w/v) solution was infused slowly over 20 to 30 minutes, and several
pressor responses to the same dose of angiotensin recorded again. To
produce a reduction in the extracellular sodium concentration Tyrode
solution with its sodium chloride replaced iso-osmotically by sucrose was
injected intraperitoncally and re-aspirated 25 to 30 minutes later, this
being repeated two or three times. After this, the arterial cannula was
replaced by another clean dry one and a second sample of blood collected
through this. The electolyte concentrations of the serum was determined
using a Unicam spectrophotometer. The significance of the differences
between the means of the maximum pressor responses to angiotensin was
assessed by the 't' test. The results are summarised in table 4. Significant
differences were observed following an increase in potassium (P»0.05) and
calcium (P<*0.0l).
These results show that either an increase or a decrease in the
extracellular sodium within the range of chcinge achieved failed to influence
the response to angiotensin to a significant degree (PKi.Op). However, the
responses after a decrease in the sodium do show a tendency if at all to be
greater than the control period unlike when the sodium was elevated. This
is in keeping with the common observation that the constrictor response of
smooth muscle is potentiated by a decrease in the extracellular sodium
(Napodano et al 1962} Friedman, Jamieson and Friedman 1959} Bohr, Brodie
and Cheu 1958} Dodd uud ^aniel i960). This would rule out the suggestion
made in section 1 that progesterone brings about its effect of decreasing
the pressor response to angiotensin by a sodium depleting action. Caution
is necessary in interpreting the results in this way however since Hinke
and Wilson (1962) have reported that in the rat tail artery preparation
decreasing the extracellular sodium leads to a decrease in the response to
angiotensin.
The finding that an increase in the extracellular potassium ion
concentration results in an increase in the response to angiotensin is in
agreement with the findings of others (Hinke and Wilson 1962). This may be
interpreted as Bhowing the importance of changes in membrane excitability in
the action of angiotensin. Bohr, Brodie and Cheu (195®) have shown that a
decrease of the K+inside/K+outside ratio by increasing the external potassium
concentration increases the responsiveness of arterial smooth muscle to
another vasoactive substance - adrenaline. The importance of the membrane
potential has also received some confirmation by the work of Dodd and Daniel
(i960). Several workers have shown that all classes of drugs that activate
or inactivate smooth muscle cells have similar actions on their depolarised
counterparts (Singh and Acharya 1957} Evans,Schild and XheBleff 1958).
This however does not mean that the electrical activity at the membrane does
not contribute to the mechanical changes but rather that depolarised smooth
muscle serves as a model preparation in which one component of the action of
drugs can be studied in isolation. Thus Bohr (1964) has presented evidence
to show that the drug induced tension development in vascular smooth muscle
has a fast component, rate-limited by events occuring at the membrane and a
slow component, rate-limited by the excitation contraction coupling process.
He has proposed that the rate-limiting factor in the action of angiotensin
is associated with membrane excitability.
Another interpretation of the enhancing effect of an increased
extracellular potassium ion concentration on the response to angiotensin is
suggested by the work of Head (1955)• He has observed that angiotensin
causes potassium to move into cells when the extracellular potassium
concentration was high. There is also evidence that the entry of potassium
into vascular smooth muscle cells is easier than into other cells and that
an increase in the intracellular concentration of potassium leads to an
increase in tension development (Lasat i960). This is, however, contrary
to the view proposed by Friedman and Friedman (1964) that the movement of
sodium ions into the cell initiates contraction.
Calcium ions have been shown to play an essential role in the drug
induced contraction of arterial smooth muscle by Waugh (1962b) and Bohr and
Goulet (1961). Calcium has been associated with the chemico-meclianical
transducing process in the contractile proteins of skeletal and cardiac muscle,
and by analogy probably plays a similar role in vascular smooth muscle cells.
A great deal of evidence points to the fact that the final common pathway by
which drugs induce contraction of smooth muscle is by elevating the level of
free intra-cellular calcium (Daniel 1963)* This may be achieved either by
increasing the permeability of the cell membrane so that extracellular
calcium can reach the cell interior down a concentration gradient, or by the
liberation of bound calcium into the cell interior. The first possibility is
considered to be more likely because in smooth muscle there is little
endoplasmic reticulum and none of the complicated apparatus present in
skeletal muscle which ensures the liberation of calcium close to the filaments
of contractile protein. Further the diameter of the smooth muscle cell is so
much less and the speed of response so much slower that simple diffusion of
calcium may be a sufficient mechanism. This is probably the interpretation
of the increased response to angiotensin in the presence of an elevated
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B ® Before administration of drug





























































B = Before administration of drug.
















12.9 1.1 0.7 >0.05
11.9 4.0 2.3

































































MEAN RESPONSE TO 4ng CHANGE IN SERIUM ION CONC.
I—
ION VOL.
ANGIOTENSIN MM. Hg BASAL meq/l ADDED INF. P
B.P.MM.Hg. rag ml
BEFORE AFTER BEFORE AFTER
INCREASED SODIUM
14.0 12.0 -65 152.2 160.0 32.1
[
0.7
8.7 8.3 -48 134.8 142.6 36.7 0.8 >0.05
10.7 10.0 -60 120.9 130.4 32.1 0.7
7.0
•
• -35 138.3 145.7 32.1 0.7
DECREASED SODIUM
16.5 19.3 -30 101.3 90.4
17.1 15.4 as 110.4 106.5
> 0.05
13.0 23.5 -60 110.4 88.7




4.3 15.8 -64 5.8 8.3 4.2 0.2
7.0 22.0 —42 4.3 5.7 3.2 0.15
10.8 19.8 -38 4.4 5.2 4.2 0.2
= 0.05
14.0 8.0 -14 4.9 5.2 2.1 0.1
9.3 21.8 -36 3.9 5.8 2.1 0.1
11.3 13.1 -38 4.6 5.8 2.1 0.1
INCREASED CALCIUM
9.2 13.1 -30 5.3 6.7 5.3 0.6
7.4 9.6 -48 5.3 5.8 3.5 0.4
10.6 14.2 -45 5.3 7.2 3.5 0.4 < 0.01
10.7 14.0 -28 4.8 5.7 0.9 0.1






(a) Effect of angiotensin on vascular resistance in the hind limb.
The dogs were anaesthetised with intravenous pentobarbitone
(l30mg/Kg u)| small doses being administered subsequently during the
experiment to maintain the level of anaesthesia. The abdomen was opened
through a mid line incision and the lumbar sympathetic chain on one side
identified. The last lumbar ganglion was located and two loose ligatures
placed distal to it for subsequent identification and tying. The femoral
arteries were exposed in the femoral triangles and each one was cannulated
proximally and distally. Each proximal cannula was connected to its
corresponding distal cannula by plastic tubing which passed through a
constant flow Sigiuamotor pump. Two double limb mercury manometers
connected to a point distal to the pump were used to record the perfusion
pressures of the limbs. The systemic pressure was measured by a third
manometer connected to one of the proximal cannulae in one of the femoral
arteries. The flow in the arteries was occluded only briefly during the
cannulation and connecting up procedures and the animal was heparinised
(5mg/kg < ) before flow through the external circuit was started. The
speed of the pump was adjusted initially to give a perfusion pressure in
the limbs equal to the systemic pressure. The external tubing was water
jacketed and each side had a volume of approximately 20 mis. Intra¬
arterial injections were made through short lengths of rubber tubing between
the distal arterial cannula and the plastic tubing. Intravenous injections
were made into a cannulated femoral vein. A dose of angiotensin which gave
an elevation in the perfusion pressure of about 20mm. of mercury on intra —
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arterial injection was selected and used throughout each experiment. Ten to
fifteen minutes after the operative procedure was completed responses of
both limbs to the intra arterial injection of the selected dose of
angiotensin was recorded. The sympathetic trunk on one side was then tied,
using the ligatures placed before hand, and sectioned between the ligatures.
The responses to the same intra-arterial dose of angiotensin was recorded
subsequent to this. Bipolar electrodes were placed on the distal end of the
cut sympathetic nerve^isolated from surrounding tissues and stimulated
using pulses of 1 msec duration. Responses to angiotensin were recorded
both during and after stimulation of the nerve. The effect of a variety
of drugs on the response to angiotensin was then tested.
(b) The effect of generalised sympatnetic activity on the pressor action
of angiotensin.
Anaesthesia was induced using ether, and intravenous chloralose used
for maintainence, and the dog prepared as in (a) above. Attempts to increase
the general sympathetic discharge by brief occlusion of the carotid arteries
failed as shown by a lack of elevation in the systemic blood pressure. An
elevation of the systemic pressure was however acheived by distention of
the bladder with warm saline solution. Responses to intravenous and
intra-arterial angiotensin were recorded both before and during such
distention of the bladder.
(c) Effect of angiotensin on sodium ion movement.
Dogs under pentobarbitone anaesthesia were used. Through a mid line
abdominal incision the renal pedicles vers cleared and firm ligatures tied
round them to occlude the renal arteries. Raffinose (60mg/k^. ) was then
administered intravenously. An internal jugular vein and a carotid artery
were cannulated in the direction of the heart. Blood from the carotid
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artery was lead by means of plastic tubing through a sigmamotor pump to
either an iliac or femoral artery cannulated in the direction of the limb.
The perfusion pressure of the limb and the systemic pressure were measured
by double limb mercury manometers recording on smoked paper connected distal
to and proximal to the pump respectively. The iliac or femoral vein of the
perfused limb was cannulated and the blood leaving the limb was lead through
a specially designed chamber containing a sodium electrode. From this chamber
the blood was returned to the circulation via the cannulated internal jugular
vein. A short side arm in the tubing beyond the chamber containing the
sodium electrode enabled samples of blood to be collected when the electrode
indicated that changes in the sodium concentration were occuring. The
external tubing had a volume of about 50 ml. The tubing and the chamber
containing the sodium electrode weinewater jacketed and maintained at a
constant temperature of about 38°C. The animal was heperinised (5mg/kg)
before flow through the external circuit was started. Angiotensin and other
drugs were dissolved in a solution of four parts of isotonic saline to one
part of 5* dxtrose solution. Preliminary trials had shown that this mixture
did not affect the sodium electrode when injected into the circulation of
the limb by itself. The samples of blood that were collected were
centrifuged7the plasma pipetted off and analysed for sodium and raffinose
concentrations. Sodium concentration was determined on a Unicom flame
spectrophotometer (SP.9U0) and the following procedure was adopted for
analysis of raffinose (modification of method described by Higashi and
Peters 1950). 6ml. of distilled water and 2ml. of trichlor acetic acid
(13*) were added to 0.2ml. of the plasma and the mixture centrifuged after
shaking up. To 1ml. of the supernatant was added 1ml. of resorcinol
(O.lg/lOOml. ethanol), the mixture cooled in ice and 3ml. of concentrated
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HC1 (S.G. 1.19 containing 7.5®g* FeCly'l) then added. The solution was then
transferred to a water bath at 80°C for 10 minutes at the end of which the
reaction was stopped by cooling in ice and the optical density of the eolation
measured in a Unlearn spectrophotometer (SP.500) at a wavelength of 480mju.
The concentration of raffinose was derived from a comparison with solutions
containing standard amounts of raffinose.
RESULTS AND DISCUSSION
(a) Effect of angiotensin on the vascular resistance of the kind limb.
Under the conditions of constant flow obtaining in these experiments
the changes in the perfusion pressure of the limb sire proportional to changes
in the vascular resistance. The protocols of the experiments are given in
table 5(a) to (e).
The effect of sympathectomy alone on the perfusion pressure of the limb
was variable. In three experiments the perfusion pressure was reduced
indicating a vasodilatation! In two of the experiments there was no change
in the perfusion pressure after sectioning the sympathetic trunk. The effect
of sympathectomy on the response to angiotensin was also variable. On two
occasions it was reduced on two occasions there was no effect and in one
instance there was a marked enhancement of the response. There was also no
correlation between the change in resting perfusion pressures following
sympathectomy and these effects on the response to angiotensin.
The effect of stimulation of the distal end of the severed sympathetic
trunk was to elevate the perfusion pressure indicating a vasoconstriction tn
the limb vasculature on the side concerned. An interesting effect was
noticed in experiment (e) where stimulation of the sympathetics lead, in
addition, to a fall in the perfusion pressure in the opposite limb indicating
a vasodilatation there (Figure 5)* This was noticed twice at two different
strengths of stimulation and was abolished when atropine was administered
intravenously. Cholinergic vasodilator fibres have been shown to exist in
the sympathetic outflow to the lower limb of the dog by several workers
(Bulbring and Burn 1935; Furmin, Ngai and Wang 1953; Clonninger and Green
1955; Youmans, Green and Denison 1955) but these results would seem to
suggest that there is a crossing over of these fibres at a low level as well.
The effect of nerve stimulation on the response to angiotensin was again
variable. In general the direction of change was opposite to the direction
of change following sympathetomy} where sympathectomy had reduced the
response stimulation of the nerve tended to restore it, while where there had
been no change, stimulation too had no effect. In experiment (e) where
there was a vasodilatation in the opposite limb, the response to angiotensin
in that limb was definitely potentiated during nerve stimulation and this
effect was once again abolished by atropine administration.
These results suggest that the relationship between the sympathetic
nerve supply and the response of the hind limb vessels of the dog to
angiotensin is not as straight forward as suggested by the work of
Zimmerman (l?62). To the extent that stimulation of the nerve tends to
counteract any effect that sympathectomy had on the response to angiotensin,
the sympathetica may be said to influence the response to angiotensin, but
in these results the direction of this influence seems to be quite variable.
The enhancing effect of an activation of the cholinergic vasodilator fibres
as seen in experiment (e) leads one to speculate whether this effect may account
in some way for the differences in this study and that of Zimmerman.
If angiotensin is assigned the ability to either liberate noradrenaline
from sympathetic nerve endings or to enhance its release from this site
or to interfere with the re-uptake and inactivation process of nor¬
adrenaline one would have expected far more clear cut results from this
experimental preparation. Experiment (e) shows also that even an infusion
of angiotensin failed to influence the constriction due to sympathetic
stimulation.
Calcium gluconate and desmethylimipramine did not influence the response
to angiotensin. An infusion of noradrenaline was similarly ineffective.
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An intra-arterial infusion of adrenaline increased the response to angiotensin
on two occasions but on two others it had little or no effect. Thus unlike
the case of oxytocin an adrenaline infusion after sympathectomy, in the
presence or absence of atropine fails to have a consistent effect on the
response to angiotensin.
Dihydroergotamine was found to increase the response to intra-arterial
angiotensin more specially on the side that had been denervated (Fig. 4).
The interpretation of this finding is doubtful. Bevis and Mohme-Lundholm
(1966) have shown that in isolated bovine arteries dihydroergotamine at a
-6
concentration of 10 increases the concentration of ATP and CP. This was
accompanied by a gradual increase in the tension of the artery. In this
study too b.H.E. intra-arterially invariably produced an elevation of the
vascular resistance and the increased responses to angiotensin in the
isolated perfused limb may be related to the elevation in the energy rich
organic phosphate compounds in the vascular smooth muscle cells.
(b) The effect of generalised sympathetic activity on the pressor action
of angiotensin.
The results of the few experiments that were done were entirely
negative. No difference in the response to angiotensin administered
intravenously or intra-arterially into the limb circulation was observed
tither after or during a generalised increase in sympathetic activity.
Again some difference would have been expected if angiotensin influenced the
events occuring at the sympathetic nerve terminals.
(c) The effect of angiotensin on ion movement*
Friedman, Butt and Friedman (1957) have shown that the vasoconstrictor
action of angiotensin is accompanied by a decrease in the extracellular
sodium ion content. A similar change was produced by other vasoconstrictors,
while vasodilators had the opposite effect. They have proposed on the basis
of subsequent work (Friedman and Friedman 1964) that these movements of
sodium are causal in the production of constriction and relaxation, of the
vascular smooth muscle cells. In these studies water was found to move with
the sodium. The necessity for such a movement of water however can be
obviated if the inward movement of sodium is accompanied by a simultaneous
outward movement of a corresponding amount of potassium. It has been found
by the same workers that vasoconstriction due to vasopressin and noradrenaline
is accompanied by an outward movement of potassium but the constriction due
to angiotensin did not produce any shifts in the potassium. It would
therefore be expected that angiotensin should produce the largest shifts in
water. However in the studies of Friedman and co-workers water movement
accompanying the inward shift of sodium was minimal in the case of
vasopressin so that with this drug the extracellular sodium concentration
decreased most; with noradrenaline the shift in water closely paralled the
shift in sodium so that plasma concentration of sodium hardly changed, while
with angiotensin the change in the plasma sodium was intermediate to that
caused by vasopressin and noradrenaline. It had been noticed earlier
(Lloyd and Pickford unpublished observations) that in the hind limb
circulation of the dog an intra-arterial injection of oxytocin produced
an increase in the plasma sodium - interpreted as a movement of sodium out
of the vascular smooth muscle cells - accompanying the vasodilatation.
This was in agreement with the hypothesis proposed by Friedman et al•.
When however the dilator action of oxytocin was converted to one of
constriction by the administration of an alpha blocking agent the shifts in
sodium accompanying the vasoconstriction were the same as that during the
previous vasodilatation on many occasions. For these two reasons and
because of the reported effects of the sympathetica on the angiotensin
response, it vas decided to investigate ion and water shifts in the hind limb
preparation of the dog during angiotensin induced vasoconstriction in the
presence and absence of blocking agents. farther since the shifts in ions
following noradrenaline administration have been reported to be abolished
by alpha blocking agents and since these substances are believed to act
cojapetitively by attachment to the receptor site it was of interest to
see whether the blocking agents themselves produce any ion shifts.
The method used to study these changes in the hind limb of the dog
is basically similar to that used by Jaiaieson & Friedman (19&1) except for
the additional use of raffinose and blood sampling in order to estimate
not only shifts in sodium but also shifts in water. The fixed quantity
of angiotensin, selected for each experiment on the basis of an adequate
constrictor response in the limb without influencing the systemic pressure,
was injected through out into the tubing between the Sigmaaotor pump and
the arterial cannula. The sodium electrode did not always show the
expected change in the sodium concentration even after allowance was made
for the delay in flew between the venous side of the limb and the
electrode. Blood samples were therefore collected from the venous side
at a fixed interval of time after the angiotensin injection shown by trial
to allow for the delay in the flow. The volume of the samples were the
same through out an experiment.
The raffinose concentration of a sample was converted to a percentage
change as compared with that of a control sample taken at the beginning
of the experiment, that is after about one hour had been allowed for the
raffinose to equilibriate. After blocking agents fresh controls were
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taken and subsequent samples compared with these. An increase in the
raffinose concentration was denoted by a + and would indicate a shift of water
out of the extracellular compartment. ilaffinose was used instead of the more
conventional inulin as it was hoped its smaller molecular size would enable
the vascular and interstitial compartments to come into equilibrium more
rapidly so that the simplifying assumption that changes in the plasma
concentration is equal to the extracellular fluid concentration could be
made. The changes in sodium concentration were similarly expressed as a
percentage of the control value, denoting an increase and - denoting a
decrease. These changes in concentration were however influenced by the
shifts in the water, so that the true changes in the sodium concentration
were calculated from the expression*
True per cent change in Na conc. » Observed per cent change in Na
cone• - Per cent change in raffinose conc.
Too much cannot be read into these results however as there are possible
errors in the simplifying assumptions and above all steady state conditions
were not being observed and continuously varying exchanges are being
quantified by the discontinuous process of sampling. However the results
should be valid as far as the broad pattern of changes go. The results
are sun&iarised in table 6 and in figs 6 & 7»
These results show that angiotensin does not induce shifts in sodium
or water consistently either into or out of the cells. The blocking
agents by themselves do not appear to effect any consistent pattern of ion
shifts nor do they appear to affect the ion shifts due to angiotensin.
These results are therefore not in agreement with those of the Friedraans'
and suggest that the movement of sodium ions are not directly related to the
constrictor effect of angiotensin. This is in keeping with the data of
Turker, Page and Khairalltdi (19&7) who found that in the canine arterial
?y
22
aiaooth muscle angiotensin did not influence the rate of influx of Na or its
equilibrium level but increased the Na"efflux correlated with the contraction*
Other drugs were found by these workers to influence the Na fluxes in
different ways and these could be modified by various means without
affecting the mechanical actions induced by these drugs*
TABLE 5 a
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0.5pg Angiotensin l.A. + 30 ♦ 18
SYMPATHECTOMY * m
0.5pg Angiotensin + 14 ♦ 12
STIMULATION OF NERVE (4/eec 1.5 V) * + 10
0.5^g Angiotensin l.A. + 28 + 18







G»$)ig Angiotensin l.A. * * 17
Calcium gluconate 0.5mg/mt
l.A. infusion « ■I
0,5jig Angiotensin * ♦ 14
STIMULATION ON * ■
0.5pg Angiotensin + 20
CALCIUM & STIMULATION OFF * -
Angiotensin O.lpg/mt I.A.
Infusion * + 6
STIMULATION ON FOR 1 win * + 14
H
+ 18
Angiotensin infusion off - 6
0.5pg Angiotensin I.A. + 36 *








l.A. infusion - *
0.5jug Angiotensin I.A. + 34 *
Calcium infusion off *
Adrenaline 2.5»g7«t I.A.



















Dihydroergotamlne lag I.V. - 44 & + 44 + 30
Q»5p& Angiotensin I.A.
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Adrenaline 0.25jag/»t I.A. infusion + 16 *
0.5pg Angiotensin I.A.
Adrenaline infdsion off











































+ 17 + 34
at *
+ 20 + 33
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STIMULATION OF HIE NERVE (6/sec 2 V)
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Effect of sympathectomy and stimulation of sympathetica on the
vasoconstrictor action of angiotensin in the hind lirab of the dog perfused























3jig Angio I.A. 1.3 -8.5 124.0 +1.96 +10.5
HttENTOLAMINE
5mg I.A. 1.6 +13.4 118.0 -3.0 +10.4
3p.g Angio I*A* 1.3 -17.4 119.0 +0.9 +18.3
3jig Anglo I.A. 1.6 0 123.5 +4.7 +4.7
PRGNETHANOL
25rag I.A. 1.82 -13.1 121.6 +3.1 +16.2
3jig Angio I.A. 1.8 -3.8 123.5 +1.6 +5.4
DB1YDROERGOT-
AMINE 4mg I.A. 1.8 -3*3 121.0 -0.5 +2.8
3jig Angio I.A. 1.7 -2.3 124.0 +2.5 +4.8
CONTROL 4.4 116.0
2pg Angio I.A. 4.7 +6.8 111.0 -4.3 -11.1
PH ENTGLAMINE
2mg I.A. 4.2 -4.5 115.0 -0.9 + 3.6
ljig Angio I.A. 4.4 +4.8 113.0 -1.7 + 3.1
PRONETHANOL
7mg I.A. 3.9 —7.1 111.0 -3.5 — 3.6
lyig Angio I.A. 3.8 -2.6 113.0 +1.8 + 4.4
CONTROL 6.8 119.0
3jig Angio I.A. 6.8 0 115.0 -3.4 - 3.4
2jig Angio I.A* 6.6 -2.9 112.0 -5.9 - 3.0
PHENTOLAMINE
5mg I*A. 6.4 +5.9 118.0 —0.8 - 6.7
,^ig Angio I.A. 6.4 0 110.0 -6.7 - 6.7
FHGNETHANOL
25mg I.A. 6.5 +1.3 121.0 +2.5 + 1.2
























3pg Angio I.A. 5.2 0 139.0 +5.3 +5.3
2pg Angio I,A. 4.7 -9.6 141.0 +6.8 +16.4
PHENTOLAMINE
75mg I.A. 5.9 +13.4 141.0 +6.8 -0.6
2jag Anglo l.A. 6.5 +10.2 139.0 -1.4 -11.6
PRONETHANOL
50ntg I.A. 6.5 +10.2 134.0 -5.0 -15.2
2p.g Angio l.A. 7.5 -15.4 134.0 0 ♦15.4
CONTROL 4.6 128.0
ljig Angio l.A. 4.7 +2.1 126.0 -1.6 -3.7
CONTROL 4.7 130.0
FHENTOLAMINE
2.5®g I.A. 5.7 +21.3 126.0 -3.1 -24.4
ljig Angio l.A. 3.3 -42.1 126.0 0 +42.1
CONTROL 3.2 134.0




3.7 +15.6 131.0 -2.2 -17.8
DIHYDROEPLOTAMINE
2iag X.A. 3.6 -2.7 123.0 -4.5 -1.8
lp.g Angio l.A. 3.3 I ® . 126.0 —0.8 +7.5
ljig Angio I.A. 3.2 +11.1 128.0 +2.4 -8.7
CONTROL 2.2 138
lftg Angic l.A. i.e -18.1 136.0 -1.4 +16.7
2jig Angio I.A. i.e -18.1 140. G +1.5 +19.6
PRONETHANOL
30mg I.A. 2.0 -9 • 1 141.C +2.2 -11.3














2jig Angio I.A. 1.7 +21.4 136.0 0 -21.4











































Sodium and water shifts measured in the venous blood from the hind
limb of dogs following a single intra-arteri&l injection of angiotensin.
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Sodiun and water shifts
following the intra-»rt<>rial
Figure 7
in the vonoue blood from the hind lirab of doge
administration of blocking agents.
CHAPTER 6
EXPERIMENTS USING ISOLATED BLOOD VESSELS
71
METHODS
(a) In these experiments arterial segment* from rats were perfused with Krebs
solution. The rats were anaesthetised with pentobarbitone and different main
arteries were canrsulated usually through the aorta while still in situ. The
artery was then dissected free and severed distaily so as to leave 5 to 10 mm
attached to the cannula. The arterial segments were removed to a 5ml organ
bath and perfused at a constant rate using a Sigraamotor puiap. The Krebs
solution was gassed with 95$Og & 5^C0g and had the following composition
(tnM/l) 142 Naj 5 K+J 1.3Co|* 1.3 Mg*130 el; 30 HC0~ j 1.3 SO*. 1.2
18 Glucose. The perfusate escaped frora the cut end of the artery into the
organ bath and was drawn off at the top so that the artery was totally
immersed in the liquid in the bath. The temperature throughout was maintained
at 37°C. The section of tubing between the pump and the arterial cannula
was kept as short as possible and contained a 'T* junction from which the
perfusion pressure of the artery was registered kymographically using a
Condon mercury manometer. When the perfusion was commenced the lone of the
arteries was high but within 15-20 mins the arterial segment relaxed end the
rate of perfusion was then adjusted to give a resting baseline perfusion
pressure of about 40~60iam of mercury. Tho base line pressure was well
maintained in most preparation and the rate of perfusion was in the range of
4-6ml/min. In some experiments two fine platinum wires were wrapped round
the artery over the section covering the cannula so that electrical
stimulation could be applied. Vasoactive agents were administered into the
tubing between the p;unp and the artery as either single injections when the
drug was dissolved in not more than0-0jml of the perfusate to minimise the
injection artefact on the pressure record or as continuous infusions using
a Palmer infusion pump. 0.1 mg ascorbic acid per ml was added to solutions
of noradrenaline to prevent oxidation. To decrease the concentration of
an ion in the perfusate it was replaced by an iso-osmotic amount of sucrose.
Depolarising Krebs solution was prepared by replacing part of the NaCl by an
osmotically equivalent amount of potassium sulphate so that the total
potassium ion concentration was equal to 118mM/l. The calcium ion content
of this solution was increased to 10mM/l to allow for ion pair formation.
In a few experiments chronically denervated renal arteries were used.
Under ether anaesthesia the abdomen was opened and the adventitial coat
was stripped off the renal artery close to its origin from the aorta.
The stripping was done under a dissecting microscope. The abdomen was
closed and 7 days later the animal killed and the renal artery cannulated
and perfused as in the other experiments.
(b) In these experiments segments of human umbilical arteries were used.
The umbilical cords were damped at both ends and placed in cold Tyrode
solution immediately after delivery and were used within half an hour.
A six inch length of the cord free from knots was selected and one of the
arteries cannulated at the foetal end. The piece of cord was then
transferred to warm solution to relieve the spasm of the arteries. Warm
solution was then pushed through the artery by means of a syringe to wash out
any blood inside the artery, and the placental end of the artery was also
cannulated. The piece of cord was then held vertically in an organ bath
and perfused through the foetal end at a constant pressure head of about
te
70mm of merciiry using a Mariot^bottle. The solution used had the following
composition (g/L)NaCl 9.00; KC1 0.42; CoCl,, 0.24; NaHCOj 0.2; Dextrose 1.0
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was gassed with 90$ 0^ and 5$ C0^ and maintained at 34°C (Gokhale, et al
B Heilitir 1966). The organ bath was also water jacketed and contained a
small quantity of the solution surrounding the cord. The outflow from the
placental end of the artery was led through the bottom of the organ bath to
a Palmer drop counter recording on smoked paper. Drugs were injected into
the perfusion stream close to the foetal end of the artery.
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RESULTS & DISCUSSION
In studies on the effect of drugs on vascular smooth muscle the
preparation used most frequently is the isolated rabbit aorta Btrip.
This preparation is open to the objection that a large elastic vessel
is used and the tension-length measurements are difficult to translate into
meaningful pressure-radius parameters. The perfusion of isolated segments
of artery have the advantage of maintaining the anatomical configuration
of the muscle fibres permitting measurements of changes in the vessel tone
in a manner which is more physiological. Burton & Stinson (i960) have
shown that in such perfused segments of arteries under conditions of
constant flow changes in the active tension of the sgiooth muscle cells of
the vessel wall produce linearly related changes in the perfusion pressure.
The arterial stuiap can be made to constrict either by the injection
of drugs into the perfusion stream or by stimulation of the nerves through
the electrodes wrapped round the end of the artery. That such electrical
stimulation produced a constriction via the perivascular nerves and not by
stimulation of the muscle cells directly was shown by the finding that
bretylium administration or withdrawal of calcium from the perfusate lead
to abolition of the response, while injected nortirenaline still produced
a contraction.
Several arteries from the rat (carotid, femoral, iliac, superior
mesenteric & renal) were tested and some typical results are shown in
J
Fig. 8. Noradrenaline produced a constriction in all of them and in a
given artery after the first few doses a given dose of noradrenaline
produced reproducible responses on repeated administration. The
constrictor response to angiotensin was slower in onset and disappearance
s
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when compared with the response to noradrenaline and all the arteries
developed tachyphylaxis to angiotensin on repeated administration. The renal
artery of the rat was however peculiar in not showing a constriction to
angiotensin even on its first administration. As large a dose as 0.5 mg
was found to be ineffective in the renal artery. This has been confirmed
very recently by Hrdina, Bonaccorsi and (larattini (19^7)• Kenal arteries
from dogs and rabbits were also tested, and only those from rabbits were
found to be responsive to angiotensin (fig. 9)*
Although angiotensin by itself did not produce a constriction of the
renal artery, it was noticed that subsequent responses to noradrenaline were
potentiated for periods from 15 to 45 mins after the injection of angiotensin
(Fig. 10). The potentiating effect could however be maintained by an
infusion of angiotensin into the perfusion stream close to the arterial
cannula. The concentration of angiotensin required to produce a potentiation
varied from preparation to preparation but averaged 2.5ftg/ml of perfusate.
Some preparations were affected even at a dose of 0.01 pg/ml. The degree of
potentiation was not dependent on the dose of angiotensin used but had an all
or none character. The degree of potentiation was also variable from artery
to artery. A typical dose response curve of a renal artery to single
injections of noradrenaline before and after an infusion of angiotensin is
f
shown in table "J and figure 11 and it can be seen t,hat the potentiation is
effective over a large range of noradrenaline dose. A similar potentiating
action is seen during continuous infusions of noradrenaline (fig.12).
Oxytocin vasopressin, tyramine, 5-hydrO<ytryptamine, adrenaline and nerve
"v
stimulation also produced constrictor responses in the renal artery, but
of these only the responses to adrenaline,tyramine and nerve stimulation were
potentiated by angiotensin (fig. 13)• It may therefore be concluded that
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the potentiating action of angiotensin was confined to the catecholamines
and procedures that may he expected to release catecholamines, from tissue
stores. In the other arteries that were tested angiotensin did not show
this potentiating effect consistently and when it did occur it was only to
a slight extent. The lack of an effect of angiotensin on the response of
the superior mesenteric artery of the rat to noradrenaline has also been
reported by McGregor (1965).
To get more information about the mechanism by which angiotensin
potentiates the response of the renal artery to chatecholamines, the effect
of cocaine on this effect was investigated. Cocaine was selected as it
seems to act fairly selectively on adrenergic transmission. There is
little evidence that cocaine has any marked effects on noradrenaline storage
or metabolism in sympathetic nerves while there is good evidence that it
acts by potently inhibiting the re-uptake of noradrenaline into the nerve
terminals. Figure 14 shows that the addition of cocaine to the perfusate
increases the response to noradrenaline as expected but the subsequent
addition of angiotensin further increases the response. Iversen (1961)
has shown that in the isolated heart at the concentration of cocaine used in
occurs at an external noradrenaline concentration of 200ng/«l. Therefore
the uptake process may be expected to be largely if not completely
inactivated in the artery preparation. The fact that angiotensin is still
effective then suggests that its action does not involve a mechanism of
inhibition of noradrenaline uptake. Vessels denervated 7 days previously
also showed a sensitisation of the response to noradrenaline when angiotensin
was infused further proving that the nerves were not directly concerned.
The influence of changes in the external ionic composition was also
tried. In these experiments a single dose of noradrenaline was used to
test the response of the renal artery stump throughout. After the artery
inhibition of the noradrenaline uptake process
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had been perfused with Krebs solution lacking a particular ion for about
30 aiin at least three responses to the selected dose of noradrenaline was
recorded. Angiotensin was then infused and the responses to the same dose
of noradrenaline recorded again. The mean response before and after
angiotensin infusion was calculated and the significance of the difference
between theia in several arteries tested using the *t' test, table 8. In a
control group of 5 arteries where normal Krebs solution was used as the
perfusate a greater response (5^.5$ average) to noradrenaline was observed
after angiotensin significant at the 0.01 level. When the sodium in the
perfusate was reduced 30^ by substitution with sucrose the difference in
the response produced by angiotensin still reached significance at the
0.01 level. With a complete withdrawal of the calcium or potassium or the
magnesium from the perfusate the difference produced by angiotensin was not
significant. Elevation in the external potassium to a concentration of
118mM/l can be expected to depolarise the cell membrane. This is usually
accompanied by an increase in the tension of the artery but it retains its
responsiveness to noradrenaline. Under these conditions however the
effect of angiotensin on the response to noradrenaline is completely abolished
(fig. 15). An increase in the calcium in the perfusate to 10iaM/l however
greatly increased (7< O-OOA ) the potentiating action of angiotensin on
the response of the renal artery to noradrenaline.
The effect on the smooth muscle cell of changes in the external ionic
composition is bound to be complex as each ion probably acts at more than
one site, and not all of these actions are at present fully understood.
Casteels & Kuriyama (1966) have shown that at least in the guinea-pig
taenia coli the potassium equilibrium potential is the main factor in the
generation of the membrane potential. Bulbring & Kuriyama (1963) have
studied the effect of changes iu the external concentration of calcium and
sodium on the same tissue and shown that an increase in the external calcium
leads to an increase in the membrane potential and rice versa. Also replace¬
ment of 30$ of the external 3odium by Tris produced a slight hyper-polarisation
of the membrane. In the absence of similar studies on vascular smooth muscle
the assumption has to be made that this tissue behaves in a similar way, fully
realising the possibility that this may prove not to be the case. If vascular
smooth muscle behaves like guinea-pig taenia coli an elevation of the external
K+ concentration to 118mM/l would greatly reduce or abolish the resting
membrane potential. Removal of calcium ions from the perfusion medium can
also be expected to reduce the resting membrane potential moderately as the
interstitial calcium concentration would also be reduced though there is
evidence that the interstitial concentration may not be reduced to zero due
probably to some sort of calcium binding. Both these changes in external
ion composition were observed to greatly diminish or abolish the influence
of angiotensin on the noradrenaline response, suggesting that this action
is linked to the membrane potential or a function dependent on it. On the
other hand when the external potassium ion concentration is lowered, a change
that would lead to hyper-polarisation of the raembrane, the angiotensin effect
is once again attenuated. Another procedure which by analogy with taenia
coli should lead to a hyper-polarisation of the membrane, viz. increase in the
external calcium concentration, however does not decrease but greatly
enhances the angiotensin effect. So that in so far aa these two ionic
changes lead to the same effect on the resting membrane potential their
influence on the angiotensin effect is not consistent. If the influence of
the ionic changes that lead to a depolarisation of the membrane is looked
at again it is clear that a reduction in the calcium has almost as big an
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influence as the increase of the potassium even though the former can be expected
to produce a smaller degree of depolarization. The results therefore point
to the involvement of calcium in the sensitising action of angiotensin.
A possible mechanism is that angiotensin exerts a permissive role in the entry
of calcium through a polarised membrane. Waugh (1^62 b) has shown that
adrenaline augments calcium induced contractions of calcium depleted blood
vessels in both normal and high potassium media, and has proposed that the
adrenergic neurohumour causes vasoconstriction by a membrane action which is
basically non electrical and which increases the availability of calcium ions
to the contractile protein in the cell. It is known also that depolarised
smooth muscle preparations allow greater freedom for the entry of external
calcium suggesting that a charged membrane forms some sort of barrier. If
angiotensin played a part in helping the entry of calcium through a charged
membrane it would account for the observation that high potassium and low
calcium media decreased its sensitising action on the response to noradrenaline.
Similarly an isolated elevation of the membrane potential by decrease in the
external potassium inhibits the sensitising action of angiotensin as
penetration of calcium is now even more difficult. This adverse effect of
hyperpolarised membrane can however be offset by an elevation in external
calcium concentration, thereby increasing the concentration gradient tending
to drive the calcium into the the cell when angiotensin is exerting its
permissive role in promoting calcium entry.
In this context it is of interest that another drug (serotonin) which
also sensitises the action of noradrenaline on isolated blood vessels also
loses its effect in high potassium solutions (de la Lande, Connell &
Waterson 1966). Though the mechanism of this sensitising action of serotonin
is not definitely known it has been shown by Vooliey (1958) that serotonin
plays a role in calcium transport across the membrane in the rat uterus, and
that it can for instance restore the response of this tissue to acetylcholine
- a drug which is itself dependent on calcium ions for its action - after
this has been abolished by the calcium chelating agent Versene. It is
therefore probable that the sensitising action of serotonin on the
noradrenaline response is mediated through its calcium transporting action.
If this is the case a close parallelism would exist between the action of
serotonin and angiotensin on vascular smooth muscle.
An alternative interpretation of the sensitising action of angiotensin
on the noradrenaline response of the renal artery may he that it is a
manifestation of the established ganglion stimulating effect of angiotensin.
This would be possible if extra-ganglionic synaptic sites existed along the
course of the renal arteries. By stimulating these cells angiotensin
would tend to increase the concentration of noradrenaline in the vicinity
of the receptor and thereby increase the response to exogenous noradrenaline.
The effects of the changes in ionic composition of the perfusion medium would
then be due to their influence on the nerve endings. The results of the
experiments where denervation was attempted are not necessarily contradictory
to this interpretation as it would be difficult to remove such synaptic
sites completely by stripping alone. Against this interpretation, however,
is the finding; that in a bretylium treated artery angiotensin is still
effective in sensitising the response to injected noradrenaline (fig.l6)
As pointed out earlier the renal artery is constricted by fairly large
doses of oxytoxin. Just as with angiotensin such a single injection of
oxytocin potentiated the responses to subsequent doees of noradrenaline.
A continuous infusion of a sub-constrietor dose of oxytocin could maintain
this potentiating effect as in the case of an angiotensin infusion (fig 17)
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Vasopressin however was ineffective in influencing the noradrenaline
response*
It was decided to use umbilical arteries as these have been reported
to be devoid of an innervation ("Von Euler 1938). A constant flow perfusion
system did not work satisfactorily in this preparation as noradrenaline failed
to induce very powerful contractions, and the tissue appeared to deteriorate
rapidly under these conditions. The constant pressure perfusion technique
was therefore adopted in these vessels. Under these conditions however
induced changes in flow are not directly proportional to changes in the
active tension developed by the smooth muscle. There is also the
additional difficulty that a constrictor drug by reducing the flow would
tend to remain in contact with the tissue for a longer length of time which
cannot be controlled.
In some of these preparations noradrenaline produced a constriction
while angiotensin was ineffective in all. On two occasions an infusion
of angiotensin was observed to produce a potentiation to the response to
noradrenaline (fig 18) as in the renal artery of the rat. More data will
however be required on this point.
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Effect of angiotensin on renal arterial segments from a dog, rabbit
and rat*
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Effect of a short
renal artery to single
Figure 10
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Effect of angiotensin on
due to continuous infusion of
Figure 12
the constrictor responses in the renal artery
different amounts of noradrenaline.
STIMULUS NA f s
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5HT 5HT ANG * 5HT
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RAT RENAL ARTERY
Figure 13
Effect of angiotensin on the constrictor response of the renal artery


















"Hi® sensitising notion of cocaine and angiotensin on the
noradrenaline response in the rat renal artery.
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Table 8
1 RESPONSES BEFORE RESPONSES AFTER DIFF. PER CENT
ANGIOTENSIN MM, Hg. MEAN ANGIOTENSIN MH Jig, MEAN OF CHANGE
MEANS
NORMAL KREBS (controls)
13.0? 17.3? 26.0; 28.0; 24.5; 24.0;
21.0; 25.5? 20.6 28.0 26.1 5.5 +26.7
25.0? 27.0? 30.0; 27.3 45.0; 39.0; 35-0; 39.7 12.4 +43.4
12.0; 11.0? 11.0? 11.3 21.0; 20.0; 18.5; 19.8 8.5 +75.2
16.0? 16.0; 16.0; 30.0; 32.0; 33.0; 15.8 +95.7
18.0; 16.5 34.0? 32.3 1
12.0; 12.0; 14.0; 25.0; 33.0? 35.0? 31.0 17.7 +27.8
15.0; 13.3
P<C 0.01 MEAN PES CENT CHANGE +54.2
Na*"REDUCED 50#
28.0; 29.0; 31.0? 29.3 39.0; 39.0; 45.0; 41.0 11.7 +39.9
39.0| 32.0; 39.0; 36.7 47.0; 40.0; 40.0; 42.3 5.6 +15.2
20.0; 20.0; 18.5? 19.5 22.0; 19.0; 19.0? 20.0 0.5 + 2.5
16.0; 19.0; 21.0; 18.7 24.5? 22.0; 22.0; 22.8 4.1 +21.9
33.0; 29.0; 32.0; 31.3 34,0; 34.0; 33.0; 33.7 2.4 + 7.7
33.0; 35.0; 35.0? 34.3 42.0; 39.C; 38.0; 39.7 5.4 + 15.7
P = 0.01 MEAN PER CENT CHANGE +17.2
K*~ FREE KREBS
21.5; 24.0; 25.0; 23.5 23.c; 24.5; 25.5 24.3 0.8 + 3.4
24.0;
17.0; 17.0; 19.0? 17.7 18.0; 20.5; 20.0; 19.5 1.8 +10.1
11.0; 12.5? 12.5? 12.0 13.0; 12.5; 13.0; 12.8 0.8 + 6.6






















































































Effect of angiotensin on the noradrenaline response in a renal
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The experiments embodied in this work closely followed those done
earlier with oxytocin. Angiotensin being a potent vasoconstrictor was not
expected to give a clear cut reversal in the vascular response as observed
with oxytocin following interference with the sympathetica or administration
of oestrogen. Statistical treatment of the pressor responses induced
in rats showed no significant influence of oestrogens on the response to
angiotensin, although animals in natural oestrus gave bigger responses than
animals in other stages of the reproductive cycle. Pregnancy and pseudo-
pregnancy were observed to depress the pressor response to angiotensin.
Evidence that this is probably due to the presence of progesterone was
found, and further it would appear that this is not a consequence of any
secondary effect of an increased level of progesterone. These findings
are clearly different from those observed with oxytocin and vasopressin
whose constrictor activities are enhanced by oestrogen and progesterone.
Drugs interfering with sympathetic transmission did not produce a
consistent effect as with oxytocin. Roserpine was found to markedly
potentiate the pressor action of angiotensin. Certain other drugs which
had the common feature of increasing the response to noradrenaline were
also found to affect the response to angiotensin in the same direction as
reserpine, suggesting that part of the pressor action of angiotensin was
mediated through processes involving the adrenergic neurohumour•
Indirect though the evidence may be the effect of changes in the
extracellular ion concentration suggested that electrical changes at the
cell membrane contributed to the constrictor response elicited by
angiotensin.
The experiments with dogs were not in agreement with those on rats.
Thus there was no evidence for an influence of angiotensin on physiological
processes occurring through the sympathetic nerves. The studies on ionic
shifts induced by angiotensin appear to contradict the findings of Friedman
et al.
The experiments using isolated arteries have shown an interesting
additional effect of angiotensin in the rat renal artery. Here, though
angiotensin had no constrictor action, it sensitised the preparation to the
action of catecholamines. The effect of drugs and extracellular ion
concentration on this effect of angiotensin is interpreted to mean that
angiotensin plays a permissive role in the entry of calcium into the
vascular smooth muscle cell.
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